Meeting
2019 Supportive Care in Oncology Symposium
Timing of adjuvant chemotherapy initiation and colon cancer survival.
Authors
Aaron Gehr
JPS Health Network, Fort Worth, TX
Aaron Gehr, Yan Lu, Bassam Ghabach, Kalyani Narra, Latha Sri Neerukonda, Jolonda Bullock, Rohit P. Ojha
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Mental Health and Psychological Well-being,Psychosocial and Spiritual/Cultural Assessment and Management,Models of Care,Patient Reported Outcomes and Patient Experience,Prevention, Assessment, and Management of Disease and Treatment-related Symptoms,Prognostication ,Survivorship and Late Effects of Cancer
Sub Track
Prevention, Assessment, and Management of Disease and Treatment-related Symptoms
Citation
J Clin Oncol 37, 2019 (suppl 31; abstr 119)
DOI
10.1200/JCO.2019.37.31_suppl.119
Abstract #
119
Poster Bd #
D8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Impact of the IDEA collaboration study on practice patterns of adjuvant chemotherapy in patients with stage III colon cancer: A population-based study.
First Author: Sunil Samnani
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Survival of stage III colon cancer patients with adjuvant chemotherapy: Experience from a specialized cancer institute in Latinoamerica-Peru.
First Author: Eder Christian Veramendi Cabana
Poster
2021 Gastrointestinal Cancers Symposium
Final results of the ACTS-CC 02 trial: A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/leucovorin as adjuvant chemotherapy for high-risk stage III colon cancer.
First Author: Naohiro Tomita
Poster
2021 Gastrointestinal Cancers Symposium
Survival outcomes of adjuvant chemotherapy in elderly patients with stage III colon cancer.
First Author: Walid Labib Shaib